Using molecular markers in sputum for the early detection of lung cancer: A review

Lung Cancer

Volumn 45, Issue SUPPL. 2, 2004, Pages

  Kennedy, Timothy C ^a,b   Hirsch, Fred R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CO 80218 USA ^*  (United States)

Author keywords

Biological markers; Non small cell lung carcinoma; Sputum

Indexed keywords

PROTEIN P53;

CANCER RISK; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DNA DETERMINATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; HUMAN; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; LUNG CARCINOMA; MOLECULAR DYNAMICS; PRIORITY JOURNAL; VALIDATION PROCESS;

HUMANS; LUNG NEOPLASMS; MOLECULAR BIOLOGY; SENSITIVITY AND SPECIFICITY; SPUTUM; TUMOR MARKERS, BIOLOGICAL;

EID: 8444223972     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.07.996     Document Type: Conference Paper

References (46)

1. Jemal A., Murray T., and Samual A. Cancer Statistics 2003 CA Cancer J Clin 53 2003 5 26
2. Kaneko M., Eguchi K., and Ohmatsu H. Peripheral lung cancer: screening and detection with low dose spiral CT versus radiography Radiology 201 1996 798 802
3. Fontana R.S., Sanderson D.R., and Taylor W.F. Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study Am Rev Respiratory Disease 130 1984 549 554
4. Fontana R.S., Sanderson D.R., and Woolner L.B. Lung Cancer Screening: The Mayo Program J Occupat. Med 28 1986 746 750
5. Melamed M.R., Flehinger B.J., and Zaman M.B. Screening for lung cancer: results of the Memorial Sloan-Kettering study in New York Chest 86 1984 44 53
6. Tockman M.S. Survival and mortality from lung cancer in a screened population: The Johns Hopkins Study Chest 89 1986 324 345
7. Kubik A., and Polak J. Int J Cancer 45 1990 26
8. Cortese D.A., Pairolero P.C., and Bergstralh E.J. Roentgenographically occult lung cancer. A ten-year experience J Thorac Cardiovasc Surg 86 1983 373 380
9. Bechtel J.J., Kelley W.R., and Petty T.L. Outcome of 51 patients with roentgenographically occult lung cancer detected by sputum cytology testing Arch Intern Med 154 1994 965 970
10. Bechtel J.J., Petty T.L., and Saccomanno G. Five-year survival and later outcome of patients with x-ray occult lung cancer detected by sputum cytology Lung Cancer 30 2000 1 7
11. Saito Y., Nagamoto N., and Ota S. Results of surgical treatment from roentgenographically occult bronchogenic squamous cell carcinoma J Thorac Cardiovasc Surg 104 1992 401 407
12. Nakamura H., Kawasaki N., and Hagiwara M. Endoscopic evaluation of centrally located early squamous cell carcinoma of the lung Cancer 91 6 2001 1142 1147
13. Van Boxem T.J., Venmans B.J., and Schramel F.M. Radiographically occult lung cancer treated with fiberoptic bronchoscopic electrocautery: a pilot study of a simple and inexpensive technique Eur Resp J 11 1998 169 172
14. Van Boxem T.J., Venmans B.J., and Postmus P.E. Curative endobronchial therapy in early-stage non-small cell lung cancer J Bronchol 6 1999 198 206
15. (7) Cortese D.A., Edell E.S., and Kinsey J.H. Photodynamic therapy for early stage squamous cell carcinoma of the lung Mayo Clin Proc 72 1997 595 602
16. Lam S., Kennedy T., and Unger M. Localization of bronchial intraepithelial neoplastic lesions by fluorescence endoscopy Chest 113 1998 696 702
17. Venmans B.J., van der Linden J.C., and van Boxem A.J. Early detection of pre-invasive lesions in high risk patients. A comparison of conventional fiberoptic and fluorescence bronchoscopy J Bronchol 5 1998 280 283
18. Hirsch F.R., Prindiville S.A., and Miller Y.E. Fluorescence versus white-light bronchoscopy for detection of pre-neoplastic lesions: a randomized study J Nat Cancer Inst 93 18 2001 1385 1391
19. Swenson S.J., Jett J.R., and Hartman T.E. Lung cancer screening with CT: Mayo Clinic experience Radiology 22 63 2003 756 761
20. suppl Henschke C.I. Early lung cancer action project: overall design and findings from baseline screening Cancer 89 11 2000 2474 2482
21. Kennedy T.C., Franklin W., and Keith R. High prevalence of endobronchial malignancy in high-risk patients who have moderate dysplasia in sputum Lung Cancer 41 suppl 2 2003 42
22. Saccomanno G., Archer V.E., and Auerbach O. Development of carcinoma of the lung as reflected in exfoliated cells Cancer 33 1974 256 270
23. Kennedy T.C., Proudfoot S., and Franklin W.A. Cytopathological analysis of sputum in patients with airflow obstruction and significant smoking histories Cancer Res 56 1996 4673 4678
24. Prindiville S.A., Byers T., and Hirsch F.R. Sputum cytological atypia as a predictor of incident lung cancer in a cohort of heavy smokers with airflow obstruction Cancer Epidemiol Biomarkers Prev 12 2003 987 993
25. Ng A.B., and Horak G.C. Factors significant in the diagnostic accuracy of lung cytology in bronchial washing and sputum samples. II. Sputum samples Acta Cytol. 27 1983 397 402
26. (8) Payne P.W., Sebo T.J., and Doudkine A. Sputum screening by quantitative microscopy: a reexamination of a portion of the National Cancer Institute Cooperative Early Lung Cancer Study Mayo Clin Proc 72 1997 697 704
27. Palcic B., Garner D.M., and Beveridge J. Increase of sensitivity of sputum cytology using high-resolution image cytometry: field study results Cytometry 50 3 2002 168 176
28. McWilliams A., Mayo J., and MacDonald S. Lung cancer screening: a different paradigm Am J Respiratory Critical Care Med 168 10 2003 1167 1173
29. Marek W., Kotschy-Lang N., and Muti A. Can semi-automated image cytometry on induced sputum become a screening tool for lung cancer? Evaluation of quantitative semi-automated sputum cytometry on radon- and uranium-exposed workers Eur Respir J 18 2001 942 950
30. Tockman M.S., Mulshine J.L., and Piantadosi S. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B2 overexpression Clin Cancer Res 3 1997 2237 2246
31. Tockman M.S., Mulshine J.L., and Piantadosi S. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression Clin Cancer Res 6 4 1997 1601 1603
32. Sueoka E., Sueoka N., and Goto Y. Heterogeneous nuclear ribonucleoprotein Bl as early biomarker for occult cancer of human lungs and bronchial dysplasia Cancer Res 61 2001 1896 1902
33. Thunnissen F.B.J.M. Sputum examination for early detection of lung cancer J Clin Pathol 56 2003 805 810
34. Feng Z., Tian D., and Lan Q. A sensitive immunofluorescence assay for detection of p53 protein accumulation in sputum Anticancer Res 19 1999 3847 3852
35. Anderson M., Sladon S., and Michels R. Examination of p53 alterations and cytokeratin expression in sputa collected from patients prior to histological diagnosis of squamous cell carcinoma J Cell Biochem Supp 25 1996 185 190
36. Kersting M., Friedl C., and Kraus A. Differential frequencies of p16(INK4a) promoter hype rmethylation, p53 mutation and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers J Clin Oncol 18 2000 3221 3229
37. Sugita M., Geraci M., and Gao B. Combined use of iligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma Cancer Res 62 2002 3971 3979
38. Belinsky S.A., Nikula K.J., and Palmisano W.A. Aberrant methylation of p16 is an early event in lung cancer and a potential biomarker for early diagnosis Proc Natl Acad Sci USA 95 1998 11891 11896
39. Palmisano W.A., Divine K.K., and Saccomanno G. Predicting lung cancer by detecting aberrant promoter methylation in sputum Cancer Res 60 2000 5954 5958
40. Zochbauer-Muller S., Lam S., and Toyooka S. Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers International J Cancer 107 4 2003 612 616
41. Hirsch F.R., Belinsky S.A., and Kennedy T.C. Aberrant DNA methylation in sputum atypia predict lung cancer - Preliminary report from the University of Colorado High Risk Cohort Study Lung Cancer 41 2003 S86
42. Varella-Garcia M., Passarini A., and Sokolova I. Chromosomal aneuploidy detected by multi-target interphase fluorescence in situ hybridization (FISH) in sputum as a predictor of lung cancer risk Proc AACR, Clin Res 44 2003 297
43. Somers V.A.M.C., Pietersen A.M., and Theunissen P.H.M.H. Detection of K-ras point mutations in sputum from patients with adenocarcinoma of the lung by point-EXACCT J Clin Oncol 16 1998 3061 3068
44. Chen J.T., Ho W.L., and Cheng Y.W. Detection of p53 mutations in sputum smears precedes diagnosis of non-small cell lung carcinoma Anticancer Res 20 2000 2687 2690
45. Lacroix J., Becker H.D., and Woerner S.M. Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by prep roGRP-specific RT-PCR Int J Cancer 92 1 2001 1 8
46. Hahn W.C., and Weinberg R.A. Rules for making human tumor cells N England J Med 47 20 2002 1593 1603